CORRECTED-UPDATE 1-Celgene to sell psoriasis drug Otezla for $13.4 bln to Amgen
Celgene Corp will sell its
psoriasis drug Otezla for $13.4 billion in cash to Amgen Inc
, taking Celgene a step closer to a $74-billion takeover
by Bristol-Myers Squibb Co.
psoriasis drug Otezla for $13.4 billion in cash to Amgen Inc
, taking Celgene a step closer to a $74-billion takeover
by Bristol-Myers Squibb Co.
Posted by Reuters
